ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1910

Development of the American College of Rheumatology Toolkit for Implementation of Rheumatoid Arthritis Outcome Measures in Clinical Practice

Catherine Nasrallah1, Lindsay Jacobsohn1, Gabriela Schmajuk2, Emma Kersey1, Cammie Young3, Cammie Young3, Janell Martin4, Lori Barber5, Jennifer Barton6, Puneet Bajaj7, Christie M. Bartels8, Sancia Ferguson9, Elizabeth Wahl10, Kimberly DeQuattro11, Patti Katz12, Maria I. ("Maio") Danila13, Meera Subash14, Christina Downey15, JoAnn Zell16, Kimberly Reiter17, Elena Weinstein18 and Jinoos Yazdany1, 1University of California San Francisco, San Francisco, CA, 2UCSF / SFVA, San Francisco, CA, 3University of California San Francisco, Oakland, CA, 4American College of Rheumatology, Atlanta, GA, 5ACR, Atlanta, GA, 6VA Portland Health Care System/OHSU, Portland, OR, 7UT Southwestern Medical Center, Dallas, TX, 8University of Wisconsin, School of Medicine and Public Health, Madison, WI, 9University of Wisconsin, Madison, WI, 10VA Puget Sound Healthcare System, Seattle, WA, 11University of Pennsylvania, Media, PA, 12University of California San Francisco, San Rafael, CA, 13University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 14University of Texas Health Science Center at Houston, Houston, TX, 15Loma Linda University Medical Center, Loma Linda, CA, 16University of Colorado Anschutz Medical Campus, Denver, CO, 17Albuquerque VA Medical Center, Albuquerque, NM, 18University of Colorado, Englewood, CO

Meeting: ACR Convergence 2023

Keywords: Education, Patient reported outcomes, Qualitative Research, quality of care, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1895–1912) Measures & Measurement of Healthcare Quality Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite significant interest in the scale and spread of rheumatoid arthritis (RA) outcome measures to facilitate a patient-centered, treat-to-target approach, use of these measures remains inconsistent among rheumatologists. We used the Consolidated Framework for Implementation Research (CFIR) to guide qualitative interviews with stakeholders about facilitators and barriers to RA outcome measurement in real-world rheumatology care, with the goal of disseminating best practices for implementation via an online toolkit

Methods: Using RISE registry data, we invited 85 practices with high performance on RA disease activity (DA) measures (≥ 50% percentile on the Quality Payment Program (QPP) 177 periodic assessment of DA) and 54 practices with lower performance to participate. Because academic medical centers (AMCs) are under-represented in RISE, 4 AMCs were also invited to participate. Rheumatologists and key staff from each practice participated in virtual interviews. CFIR concepts were used to develop a semi-structured interview guide to understand workflows, facilitators, and barriers to RA outcome measure collection. Interview recordings were transcribed verbatim and analyzed thematically using deductive and inductive techniques to generate themes and subthemes. Collaborating with the ACR staff, we compiled information from these interviews to develop the online RA Toolkit, a comprehensive resource to facilitate RA outcome measurement in clinical practice (Figure 1).

Results: Interviews were conducted with invited practices until thematic saturation was reached (38 interviews across 16 RISE practices and 4 AMC). Participants included 21 rheumatologists, 8 medical assistants, 6 practice managers, 1 nurse practitioner, and 2 information technology specialists. Each interview highlighted unique innovations, resources, best practices, and challenges for collecting RA outcome measures (select findings summarized in Table 1). Results of the qualitative interviews, ACR guidelines regarding RA outcome measures, and other evidence-based resources were compiled in the RA Toolkit (available at RAToolkit.kotobee.com). The Toolkit is a multimedia online resource for RA outcome measure implementation geared toward use by clinicians and staff. Sections include text, videos, and downloadable forms that aid in understanding and using RA outcome measures in clinical practice, recommendations and best practices identified from high performers across diverse practice settings and EHRs, training resources for staff, and validated translations of available RA measures in Spanish and Chinese (Figure 2).

Conclusion: Qualitative interviews conducted with rheumatology teams laid the groundwork to develop a best practices implementation toolkit to disseminate innovations in RA measures collection. The ACR RA Toolkit is the first comprehensive, evidence-based, open-source resource available for rheumatologists and healthcare teams to guide effective implementation, collection, and use of RA outcome measures that promote quality and value-based patient-centered care.

Supporting image 1

Figure 1: Methods for Developing the RA Outcome Measures Toolkit

Supporting image 2

Table 1: Summary of key findings from qualitative interviews about RA outcome measure collection with rheumatology practices

Supporting image 3

Figure 2: RA Measures toolkit: https://ratoolkit.kotobee.com/


Disclosures: C. Nasrallah: None; L. Jacobsohn: None; G. Schmajuk: None; E. Kersey: None; C. Young: None; C. Young: None; J. Martin: None; L. Barber: None; J. Barton: None; P. Bajaj: None; C. Bartels: Pfizer, 5; S. Ferguson: None; E. Wahl: None; K. DeQuattro: None; P. Katz: None; M. Danila: Horizon, 5, Pfizer, 5, RheumNow, 2, UCB, 2; M. Subash: None; C. Downey: None; J. Zell: None; K. Reiter: None; E. Weinstein: Priovant, 5; J. Yazdany: Astra Zeneca, 2, 5, Aurinia, 5, Gilead, 5, Pfizer, 2.

To cite this abstract in AMA style:

Nasrallah C, Jacobsohn L, Schmajuk G, Kersey E, Young C, Young C, Martin J, Barber L, Barton J, Bajaj P, Bartels C, Ferguson S, Wahl E, DeQuattro K, Katz P, Danila M, Subash M, Downey C, Zell J, Reiter K, Weinstein E, Yazdany J. Development of the American College of Rheumatology Toolkit for Implementation of Rheumatoid Arthritis Outcome Measures in Clinical Practice [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/development-of-the-american-college-of-rheumatology-toolkit-for-implementation-of-rheumatoid-arthritis-outcome-measures-in-clinical-practice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-the-american-college-of-rheumatology-toolkit-for-implementation-of-rheumatoid-arthritis-outcome-measures-in-clinical-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology